capsensixx AG: capsensixx capsensixx AG with strong 3rd quarter and significant increase in earnings

Frankfurt am Main (pta025/12.11.2020/09:05 UTC+1) * EBITDA Q.1-Q.3 2020: EUR 6,2 million (2019: EUR 4,9 million)
* EBITDA Q.3.2020: EUR 2,3 million (+40,3%)
* Earnings before taxes Q.1-Q.3 2020: EUR 4,8 million (2019: EUR 2,6 million)
* Earnings before taxes Q.3 2020: EUR 2,0 million (+126,1%)
* DVFA epS 30.09.2020: EUR 0,48 Euro (2019: EUR -0,06)

capsensixx closed the first 9 months of 2020 with a very strong 3rd quarter and a significant im-provement in earnings. After the sale and deconsolidation of coraixx GmbH & Co. KGaA, capsensixx is again generating clearly positive results. The excellent business development in the 3rd quarter provides an indication of the medium-term growth potential of the capsensixx group.

The following key figures for the years 2019 and 2020 are given before deduction of third party shares, unless otherwise indicated.

In the first nine months of 2020, EBITDA increased by 26,6% to EUR 6.2 million compared to the same period in 2019 (EUR 4.9 million). In the 3rd quarter of 2020, the increase in EBITDA intensified to 40.3% compared to the same quarter of the previous year (EUR 1.6 million) and is reported at EUR 2.3 million.

Consolidated earnings before taxes for the first nine months of the financial year 2020 were EUR 4.8 million. Compared to the same period of the previous year (EUR 2.6 million), this represents an increase of EUR 2.2 million (+82,1%). Consolidated net income after taxes for the first nine months of financial year 2020 amounted to EUR 3.5 million (+102,8% / previous year: EUR 1.7 million).
After a loss of EURO -0.2 million in 2019, earnings after taxes (without non-controlling interests) increased to EUR 1.7 million in the first nine months of the financial year 2020. In the third quarter of 2020, earnings after taxes (without non-controlling interests) amounted to EUR 0.8 million (previous year: EUR -0.1 million).

The Nine-Month Report 2020 of capsensixx AG will be available from November 12, 2020/3 p.m. at www.capsenixx.de.

(end)

Emitter:	capsensixx AG Bettinastraße 57-59 60325 Frankfurt am Main Germany
Contact Person:	Martin Stuerner
Phone:	+49 69 7680585-25
E-Mail:	vorstand@capsensixx.de
Website:	www.capsensixx.de
ISIN(s):	DE000A2G9M17 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate